Iris R. Hartley

635 total citations
23 papers, 278 citations indexed

About

Iris R. Hartley is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Iris R. Hartley has authored 23 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Iris R. Hartley's work include Parathyroid Disorders and Treatments (16 papers), Genetic Syndromes and Imprinting (6 papers) and Bone health and treatments (6 papers). Iris R. Hartley is often cited by papers focused on Parathyroid Disorders and Treatments (16 papers), Genetic Syndromes and Imprinting (6 papers) and Bone health and treatments (6 papers). Iris R. Hartley collaborates with scholars based in United States, Chile and France. Iris R. Hartley's co-authors include Michael T. Collins, Rachel I. Gafni, Kelly L. Roszko, Pablo Florenzano, Alison M Boyce, Xiaobai Li, Luis F de Castro, Edward F. Nemeth, Karel Pacák and Zahraa Abdul Sater and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Ophthalmology.

In The Last Decade

Iris R. Hartley

20 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris R. Hartley United States 9 152 114 80 72 43 23 278
Ruizhi Jiajue China 8 116 0.8× 108 0.9× 44 0.6× 63 0.9× 37 0.9× 30 316
Marilyn Kelly United States 6 98 0.6× 153 1.3× 85 1.1× 138 1.9× 17 0.4× 7 272
Pablo Florenzano Chile 13 323 2.1× 320 2.8× 159 2.0× 178 2.5× 33 0.8× 31 610
Stiina Välimäki Sweden 7 362 2.4× 228 2.0× 79 1.0× 60 0.8× 38 0.9× 7 512
Ferhunde Dizdaroğlu Türkiye 11 46 0.3× 90 0.8× 54 0.7× 39 0.5× 155 3.6× 18 309
Eva S. Liu United States 10 160 1.1× 90 0.8× 16 0.2× 55 0.8× 15 0.3× 20 302
Elizaveta Mamedova Russia 9 117 0.8× 86 0.8× 23 0.3× 20 0.3× 50 1.2× 37 193
Roxanne Merkel United States 12 140 0.9× 217 1.9× 79 1.0× 16 0.2× 100 2.3× 16 459
Eleonora Moscaritolo Italy 5 198 1.3× 92 0.8× 61 0.8× 26 0.4× 31 0.7× 6 289
Ryo-Ichiro Watanabe Japan 4 242 1.6× 90 0.8× 68 0.8× 30 0.4× 47 1.1× 7 337

Countries citing papers authored by Iris R. Hartley

Since Specialization
Citations

This map shows the geographic impact of Iris R. Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris R. Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris R. Hartley more than expected).

Fields of papers citing papers by Iris R. Hartley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris R. Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris R. Hartley. The network helps show where Iris R. Hartley may publish in the future.

Co-authorship network of co-authors of Iris R. Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of Iris R. Hartley. A scholar is included among the top collaborators of Iris R. Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris R. Hartley. Iris R. Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartley, Iris R. & Kelly L. Roszko. (2025). Treatment Advances in Tumor-Induced Osteomalacia. Calcified Tissue International. 116(1). 24–24. 1 indexed citations
2.
Farhadi, Faraz, Michael Morris, Iris R. Hartley, et al.. (2024). Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis. Arteriosclerosis Thrombosis and Vascular Biology. 44(6). 1432–1446. 2 indexed citations
3.
Farhadi, Faraz, Eve Donnelly, Iris R. Hartley, et al.. (2024). Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis. Journal of Bone and Mineral Research. 39(9). 1327–1339. 2 indexed citations
4.
5.
Hartley, Iris R., Kelly L. Roszko, Xiaobai Li, et al.. (2022). Infigratinib Reduces Fibroblast Growth Factor 23 ( FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia. JBMR Plus. 6(8). e10661–e10661. 16 indexed citations
6.
7.
Gafni, Rachel I., Iris R. Hartley, Kelly L. Roszko, et al.. (2021). The Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 (ADH1) Demonstrate Proof-of-Concept: Early Results From an Ongoing Phase 2b, Open-Label, Dose-Ranging Study. Journal of the Endocrine Society. 5(Supplement_1). A269–A269. 2 indexed citations
8.
Chu, Emily Y., Pamela J. Gardner, Olivier Duverger, et al.. (2021). A Cross‐Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis. JBMR Plus. 5(5). e10470–e10470. 10 indexed citations
9.
Gafni, Rachel I., Iris R. Hartley, Kelly L. Roszko, et al.. (2021). A Phase 2B, Open-Label, Dose-Ranging Study of Encaleret (CLTX-305) in Autosomal Dominant Hypocalcemia Type 1 (ADH1). Journal of the Endocrine Society. 5(Supplement_1). A253–A254.
10.
Hartley, Iris R., Rachel I. Gafni, Kelly L. Roszko, et al.. (2020). Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia. Journal of Bone and Mineral Research. 37(11). 2174–2185. 18 indexed citations
11.
Magone, M. Teresa, Iris R. Hartley, Edmond J. FitzGibbon, et al.. (2020). Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor. Ophthalmology. 128(4). 624–626. 10 indexed citations
12.
Florenzano, Pablo, et al.. (2020). Tumor-Induced Osteomalacia. Calcified Tissue International. 108(1). 128–142. 91 indexed citations
13.
Ovejero, Diana, Iris R. Hartley, Luis F de Castro, et al.. (2020). PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1–34. Journal of Bone and Mineral Research. 37(2). 179–184. 17 indexed citations
14.
Roszko, Kelly L., Lyndsay Smith, Mary Scott Roberts, et al.. (2020). Autosomal Dominant Hypocalcemia Type 1: A Systematic Review. Journal of Bone and Mineral Research. 37(10). 1926–1935. 20 indexed citations
15.
Gafni, Rachel I., et al.. (2020). SUN-364 Enthesophytes Are a Common Feature of FGF23-Mediated Hypophosphatemia Due to Tumor-Induced Osteomalacia. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations
16.
Collins, Michael T., Iris R. Hartley, & Pablo Florenzano. (2019). Tumor-induced osteomalacia. Elsevier eBooks. 67(E-8). 1539–1552. 2 indexed citations
17.
Hartley, Iris R., et al.. (2019). Fibrous Dysplasia of Bone and McCune–Albright Syndrome: A Bench to Bedside Review. Calcified Tissue International. 104(5). 517–529. 47 indexed citations
18.
Hartley, Iris R., et al.. (2019). Cushing disease in a patient with nonbullous congenital ichthyosiform erythroderma: lessons in avoiding glucocorticoids in ichthyosis. Journal of Pediatric Endocrinology and Metabolism. 32(8). 911–914. 1 indexed citations
19.
Sater, Zahraa Abdul, et al.. (2018). Diverticular Perforation: A Fatal Complication to Forestall in Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. 103(8). 2811–2814. 8 indexed citations
20.
Hartley, Iris R., et al.. (2013). Consideration of ICD-9 Code-Derived Disease-Specific Safety Indicators in CKD. Clinical Journal of the American Society of Nephrology. 8(12). 2123–2131. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruizhi Jiajue Breakdown of academic impact, for papers by Marilyn Kelly Breakdown of academic impact, for papers by Pablo Florenzano Breakdown of academic impact, for papers by Stiina Välimäki Breakdown of academic impact, for papers by Ferhunde Dizdaroğlu Breakdown of academic impact, for papers by Eva S. Liu Breakdown of academic impact, for papers by Elizaveta Mamedova Breakdown of academic impact, for papers by Roxanne Merkel Breakdown of academic impact, for papers by Eleonora Moscaritolo Breakdown of academic impact, for papers by Ryo-Ichiro Watanabe
Rankless by CCL
2026